Health And Medicine

Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Read More

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read More

Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read More

There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read More

Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time. Read More

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read More

The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read More

John McLean, Stevenson Professor of Chemistry and director of the Center for Innovative Technologies, has been elected a 2021 fellow of the National Academy of Inventors.  Read More

Researchers discover how a protein may treat schizophrenia, including reversing working memory deficits, a hallmark of schizophrenia for which there is currently no treatment. Read More

Dr. Sophie Katz, assistant professor of pediatric infectious diseases and associate medical director of the Pediatric Antimicrobial Stewardship Program, describes the symptoms and treatment of multisystem inflammatory syndrome in children (MIS-C). Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read More

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. Read More

Erin Calipari, assistant professor of pharmacology and a member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. Read More

Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read More

Distinguished psychology professor Jon Kaas has received the Ralph W. Gerard Prize in Neuroscience, the highest recognition from the Society for Neuroscience, for his pathbreaking work in illuminating the structure and function of the cerebral cortex and plasticity in the developing and adult brain. Read More

Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Read More

Five Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read More

Kelly Aldrich to lead year-long project modeling trends of hospital PPE. Read More

The School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation will bring together research experts on Tuesday, Nov. 30, for a virtual discussion about our current understanding of the biology of longevity. Read More

Stephen Fesik’s discovery of a cancer-targeting molecule has been made freely accessible through opnMe for global researchers to advance research into cancer therapeutics. Read More